Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Funds  >  ARCA  >  ALPS ETF    SBIO


Delayed Quote. Delayed ARCA - 09/18 08:00:00 pm
35.83 USD   -0.99%
Quotes 5-day view   Delayed Quote. Delayed Arca
09/12/2019 09/13/2019 09/16/2019 09/17/2019 09/18/2019 Date
35.97(c) 35.73(c) 36.37(c) 36.19(c) 35.83(c) Last
-1.77% -0.67% +1.79% -0.49% -0.99% Change
14 220 13 499 10 192 10 433 16 618 Volume
More quotes

Rating TrackInsight  TrackInsightTM ETF Ratings – Methodology
Investment objective
The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the Poliwogg Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.
Investment themes
Asset Classes Equities
Geographical Zones United_States
Sector Biotechnology
Size Small Cap
Development Developed
Weighting Schemes Market Cap Weighted
Index ETF Poliwogg Medical Breakthroughs TR Index - USD
Related indices
Currency USD
Management fees 0.5%
AuM (2019-09-07) 163.06 M USD
Provider ALPS
Features and characteristics
Jurisdiction United_States
Structure Open-end Fund
Date of creation 2014-12-30
Dividend Policy Distribution
Replication Method Direct (Physical)
Replication Model Full Replication
AuM evolution (2019-09-07)
Last one 163.06 M USD
1-month 167.27 M USD
3 months 156.25 M USD
6 months 166.63 M USD
1-year 244.99 M USD